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PAcute Coronary Syndromes
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n Non-Culprit De Novo Atheromatous
esions of Patients With Acute Coronary Syndromes
onstantinos Toutouzas, MD, Maria Drakopoulou, MD, John Mitropoulos, MD, Eleftherios Tsiamis, MD,
ophia Vaina, MD, Manolis Vavuranakis, MD, Virginia Markou, MD, Eirini Bosinakou, MD,
hristodoulos Stefanadis, MD, FACC, FESC
thens, Greece
OBJECTIVES We investigated whether there is increased temperature in non-culprit lesions, and the
correlation of clinical syndrome with heat production of non-culprit lesions.
BACKGROUND There is a controversy regarding whether there is widespread inflammation involving
non-culprit lesions, or whether inflammatory involvement is limited to the culprit lesion.
Coronary thermography assesses the local inflammatory involvement in atherosclerotic
lesions.
METHODS We included patients suffering from stable angina (SA) or acute coronary syndrome (ACS).
All patients had two or more angiographically detectable lesions at different arteries. Culprit
lesions should be identified in all patients. Patients with chronic total occlusions and multiple
significant lesions at the culprit vessel were excluded. We measured at each non-culprit lesion
the temperature difference (T) between the atherosclerotic plaque and the proximal vessel
wall temperature.
RESULTS The study population included 42 patients: 23 with SA, 19 with ACS. The T in non-culprit
lesions was 0.08  0.07°C. Patients with ACS had a higher temperature difference in
non-culprit lesions compared with patients with SA (ACS 0.11  0.08°C vs. SA 0.05 
0.06°C; p  0.01). The mean value of T in non-culprit lesions was higher in the untreated
group compared with the treated group with statins (0.11  0.10°C vs. 0.06  0.05°C; p 
0.05).
CONCLUSIONS The results of this study show that heat is generated in non-culprit lesions. Moreover, in
patients with ACS, temperature difference is increased compared with patients with stable
angina. (J Am Coll Cardiol 2006;47:301–6) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.069Cardiology Foundation
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Shere is a controversy regarding whether in patients with
cute coronary syndrome (ACS) there is diffuse destabiliza-
ion of atherosclerotic plaques or only the culprit lesion is
haracterized as vulnerable plaque. Several studies have
hown that non-culprit lesions are destabilized because they
ave similar morphologic characteristics with culprit lesions
etected by angiography, intravascular ultrasound, and an-
ioscopy (1–4). These studies support that there is a diffuse
estabilization of atherosclerotic plaques, leading to the
oncept that plaque instability may not represent a mere
andom vascular accident, but reflect a pan-coronary process
ecause of widespread inflammatory activation, as shown by
easuring systemic inflammatory indexes (5–7). However,
ther studies by intravascular ultrasound have shown that
ulprit lesions of patients with ACS have local morphologic
haracteristics distinct from non-culprit lesions (8–10).
Coronary thermography is a method for functional as-
essment of atherosclerotic plaques. Marked temperature
levation is shown in culprit atherosclerotic lesions. Several
x vivo and in vivo studies have shown a correlation between
nflammatory involvement and heat production in athero-
From the Hippokration Hospital, First Department of Cardiology, AthensS
edical School, Athens, Greece.
Manuscript received July 4, 2005; accepted July 20, 2005.clerotic plaques (11–15). The first ex-vivo study showed
ncreased heat production in human atherosclerotic plaques
nd a positive correlation between the concentration of
acrophages and plaque temperature (11). In vivo studies
howed that in patients with coronary artery disease a
emperature increase is observed, progressively increasing
rom patients with chronic stable angina (SA) to patients
ith ACS (16). Moreover, the anti-inflammatory effect of
ither dietary cholesterol lowering or administration of
tatins was shown to be associated with reduction of local
emperature in animals and humans (13,17).
There are no reports, however, regarding the prevalence
f temperature differences in the non-culprit lesions and
hether heat production from non-culprit lesions is associ-
ted with clinical syndromes of coronary artery disease.
hus, the goal of this study was to investigate whether there
s: 1) an increase in temperature in non-culprit lesions, and
) a correlation between clinical syndrome and local plaque
emperature measurements.
ETHODS
tudy population. We included consecutive patients with
A or ACS with de novo non-culprit atherosclerotic lesions
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Inflammation and Atherosclerosis January 17, 2006:301–6hat were subjected to percutaneous coronary intervention
or the treatment of the culprit lesion. Angiographic inclu-
ion criteria were: at least one angiographic non-culprit
esion, 20 mm in length, producing an intermediate
tenosis (50% to 75%) in vessels with a reference diameter
2.25 mm. The non-culprit lesion had to be clearly
dentified from the culprit lesion by the combination of
re-crisis and inter-crisis electrocardiographic findings, left
entricular wall motion abnormalities, scintigraphic defects,
nd angiographic lesion morphology. Two experienced
ardiologists (E.T. and M.V.) independently reviewed all
linical and angiographic data to decide angina status and
ulprit lesions before the procedure. In the case of disagree-
ent, the patient was excluded from the study.
We excluded patients medicated with corticosteroids or
onsteroidal anti-inflammatory drugs, except for aspirin. In
ddition, patients with an intercurrent inflammatory or
eoplastic condition likely to be associated with an acute-
hase response were not enrolled in the study. Patients with
hronic total occlusion, inability to detect the non-culprit
esion, or procedure failure or complication during the
reatment of the culprit lesion were excluded from the
tudy. The institutional ethics committee approved the
tudy protocol, and each patient provided written in-
ormed consent.
linical demographics. Risk factors included diabetes
ellitus, hypertension, hypercholesterolemia, and current
moking; SA was no change in frequency, duration, or
ntensity of symptoms within six weeks; ACS included
atients with unstable angina and acute myocardial infarc-
ion. Unstable angina was new-onset severe angina, accel-
rated angina, or rest angina. New-onset angina was con-
idered angina of 2 months in duration, and accelerated
ngina was considered angina distinctly more frequent,
evere, longer in duration, or precipitated by distinctly less
xertion than previously. Previous myocardial infarction
6 weeks), coronary artery bypass grafting, percutaneous
oronary intervention in other lesions, and left ventricular
unction were tabulated.
ngiographic analysis. Coronary angiograms were ana-
yzed with a computer-assisted, automated edge detection
lgorithm (Medcon, Tel Aviv, Israel) by a core laboratory
sing standard qualitative and quantitative definitions and
easurements. The outer diameter of the contrast-filled
atheter was used for calibration, and the minimal lumen
iameter was obtained from the single “worst” view.
emperature measurements. CORONARY THERMOGRA-
HY CATHETER. At the distal part of the thermography
Abbreviations and Acronyms
ACS  acute coronary syndrome
SA  stable angina
T  temperature differenceatheter, a thermistor is positioned. The technical charac- feristics of the thermistor have been previously described
16–18). Briefly, the temperature accuracy is 0.05°C and the
ime constant is 300 ms. The coronary thermography
atheter (Epiphany, Medispes S.W., Zug, Switzerland)
ontains two lumens. The first lumen runs through the
istal 20 cm of the device and is used for insertion of a
uidewire (0.014 inches). The guidewire is advanced by a
onorail system. In the second lumen, the thermistor leads
re inserted. The catheter is provided in sizes from 3-F to
.5-F.
ROCEDURE. The lesion of interest was well delineated in
wo or more views, on which the positioning of the catheter
as based. Five minutes after the last injection of contrast
edium, the coronary thermography catheter was advanced
ver the guidewire to the target vessel, and blood temper-
ture was measured when the thermistor had just emerged
rom the tip of the guiding catheter without being in contact
ith the vessel wall. Thereafter, temperature was recorded
t the proximal non-diseased segment and the most fre-
uent temperature was designated the proximal vessel wall
emperature. Afterward, temperature recordings at the ath-
rosclerotic non-culprit lesion were performed. Tempera-
ure difference (T) between the atherosclerotic plaque and
he proximal vessel wall was calculated by subtracting the
emperature at the proximal vessel wall from the maximal
emperature at the non-culprit lesion. Significant tempera-
ure difference was assigned T  0.05°C based on the
echnical characteristics of the thermistor used in the
hermography catheter (14–16). The operators had no
nowledge of the temperature measurements. The techni-
ian operators of the thermography equipment recorded the
emperature at the non-culprit lesion (18), and the analysis
f the results was preformed blindly by M.D. and J.M. The
reatment of the lesions was at the operator’s discretion.
tatistical analysis. Continuous variables are presented as
ean one standard deviation as well as median because of
heir skewed distribution. Categorical variables are pre-
ented as absolute and relative frequencies. The presented
gures show median and interquartile range (box plots)
ecause of the skewed distribution of T.
To evaluate the independent effect of clinical syndrome
nd statins on T, we initially performed an explanatory
nalysis based on non-parametric procedures. In particular,
pearman correlation coefficients and Mann-Whitney cri-
eria were applied to evaluate the associations between T
nd clinical syndrome, treatment group (statin or not), age,
ender, treated vessel, diabetes mellitus, smoking status,
ypertension, family history of premature coronary artery
isease, reference diameter, minimal lumen diameter,
spirin, beta blockers, and angiotensin-converting en-
yme inhibitors.
Then we performed multiple regression analysis using
og-T as the dependent outcome and the aforementioned
actors as explanatory variables. We have log-transformed
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January 17, 2006:301–6 Inflammation and AtherosclerosisT to fulfill the assumption of normality for the standard-
zed residuals of the regression model.
The exact p values presented arise from non-parametric
omparison and were compared with a significance level of
%. The STATA 6 software package was used for the
alculations (STATA Corp., College Station, Texas).
ESULTS
tudy population. Between November 2002 and Decem-
er 2004, a total of 42 consecutive patients fulfilled the
riteria and were included in the study. During the same
eriod, 136 patients with two-vessel disease were excluded
rom the study because the majority did not fulfill the
ngiographic inclusion criteria. Additional reasons for ex-
lusion from the study were patient refusal, inability to
dentify or disagreement on the identification of the culprit
esion, and failure or complications during the treatment of
he culprit lesion.
Of the 42 patients finally included, 19 patients had ACS
nd 23 patients had SA. The demographic characteristics
re shown in Table 1. Five patients were treated with
lycoprotein IIb/IIIa receptor blocker agents during the
rocedure. The treatment of culprit and non-culprit lesions
as left to the discretion of the operator. The majority (n 
able 1. Demographic Characteristics
n  42
ge, yrs 61.78  10.40
ale 30 (71.4)
jection fraction, % 49.27  7.67
ypertension 28 (66.6)
iabetes mellitus 13 (30.9)
amily history 10 (23.8)
urrent smoker 23 (54.8)
holesterol 32 (76.2)
tatin 29 (69.1)
spirin 38 (90.5)
ngiotensin-converting enzyme inhibitors 19 (45.2)
eta-blockers 27 (64.3)
alues are mean  SD or n (%)
able 2. Angiographic Characteristics
Non-Culprit Lesions
(n  42)
essels
LAD 7 (16.6)
LCX 19 (45.2)
RCA 16 (38.0)
ocation
Proximal 11 (26.2)
Middle 22 (52.4)
Distal 9 (21.4)
RD (mm) 2.74  0.48
Pre-MLD (mm) 0.75  0.36
Length (mm) 13.87  6.6
tenosis (%) 65.86  10.05
alues are n (%) or mean  SD.
LAD  left anterior descending artery; LCX  left circumflex artery; MLD 
inimal lumen diameter; RCA  right coronary artery; RD  reference diameter.
V7, 64.3%) of the non-culprit lesions were treated by
uccessful stent implantation.
The angiographic characteristics of non-culprit lesions
re shown in Table 2. We also categorized the study
opulation according to the clinical syndrome. The demo-
raphic and angiographic characteristics of patients suffering
rom ACS or SA are shown in Tables 3 and 4, respectively.
emperature measurements. The measurements obtained
or determination of background temperature were constant
n each patient of the total study group, varying by only
.03°C, with a standard deviation from 0 to 0.03. The
ackground temperature and the temperature of the blood
id not differ (p  0.5). In all non-culprit lesions, thermog-
aphy was performed successfully without any complica-
ions. Non-culprit lesions had a mean value temperature
ifference 0.08  0.07°C. Twenty-three patients (54.8%)
ad a significant temperature elevation in non-culprit le-
ions. The mean percentage of stenosis in non-culprit
esions with increased temperature was 67.93 10.26% and
n lesions with T0.05°C was 63.36 9.45% (p 0.15).
able 3. Demographic Characteristics Stratified by the
linical Syndrome
Acute Coronary
Syndrome
(n  19)
Stable
Angina
(n  23) p Value
ge, yrs 61.31  9.02 62.17  11.60 0.79
ale 13 (68.4) 17 (73.9) 0.74
jection fraction (%) 48.95  10.08 49.56  5.14 0.79
ypertension 13 (68.4) 15 (65.2) 0.99
iabetes mellitus 6 (31.6) 7 (30.4) 0.93
ypercholesterolemia 16 (84.2) 16 (69.5) 0.30
tatin 11 (57.8) 18 (78.3) 0.19
spirin 18 (94.7) 20 (86.9) 0.61
ngiotensin-converting
enzyme inhibitors
8 (42.1) 11 (47.8) 0.76
eta-blockers 12 (63.1) 15 (65.2) 0.99
amily history 4 (21) 6 (26) 0.70
urrent smoking 13 (68.4) 10 (43.5) 0.13
alues are mean  SD or n (%).
able 4. Angiographic Findings Stratified by the
linical Syndrome
Acute Coronary
Syndrome
(n  19)
Stable
Angina
(n  23) p Value
essels
LAD 2 (10.5) 5 (21.7)
LCX 10 (52.6) 9 (39.1) 0.54
RCA 7 (36.8) 9 (39.1)
ocation
Proximal 6 (31.6) 5 (21.7)
Middle 8 (42.1) 14 (60.9) 0.47
Distal 5 (26.3) 4 (17.4)
RD (mm) 2.58  0.36 2.87  0.54 0.06
Pre-MLD (mm) 0.84  0.26 1.02  0.40 0.12
Length (mm) 12.01  3.50 13.23  7.45 0.64
tenosis (%) 67.30  9.73 64.80  10.81 0.45alues are n (%) or mean  SD.
Abbreviations as in Table 2.
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Inflammation and Atherosclerosis January 17, 2006:301–6here was no significant correlation between mean lumen
istance and T (p  0.37).
When analyzed by the type of clinical syndrome, patients
ith ACS had higher T values compared with patients
ith SA (ACS 0.11  0.08°C vs. SA 0.05  0.06°C; p 
.01) (Fig. 1, Table 5). The percentage of lesions with
levated temperature in patients with ACS was 84.2% (16 of
9 lesions) and in patients with SA was 30.4% (7 of 23
esions) (p  0.001). Of the total study population, 29
atients received statins 4 weeks and 13 were not under
tatin treatment. The mean value of T in non-culprit
esions was higher in the untreated group compared with
he group treated with statins (0.11  0.10°C vs. 0.06 
.05°C; p  0.05) (Fig. 2).
Multiple linear regression analysis confirmed that pa-
ients with ACS had higher T compared with patients
ith SA (b standard error, 0.04 0.02, p 0.02). Statin
ntake was also a predictor for T, although statistical
ignificance was not achieved in this model (p  0.18).
ISCUSSION
he main findings of the present study are that non-culprit
ntermediate lesions have an increased temperature differ-
nce, and non-culprit lesions of patients with ACS have
ignificantly higher T compared with lesions of patients
ith chronic SA. Moreover, statins seem to have a favorable
ffect on heat generation from non-culprit lesions.
This study provides information regarding the functional
ssessment of non-culprit lesions. Current studies provide
onflicting results regarding the morphologic characteristics
f non-culprit lesions. The widespread vulnerability of both
ulprit and non-culprit lesions has been shown by several
tudies using multiple methods (1–4,6,19). The use of
ntravascular ultrasound has provided significant informa-
ion regarding this issue. Intravascular ultrasound examina-
ion has shown multiple plaque ruptures in patients with
igure 1. The difference in atherosclerotic plaque temperature from
roximal vessel wall temperature (T) in non-culprit lesions in patients
ith acute coronary syndromes (ACS) and stable angina (SA). The bottom
f the box represents the first quartile, the top of the box represents the
hird quartile, and the line in the box represents the median value.arying clinical presentations (3). Especially in patients with ACS, thrombi and multiple ruptures were more common
nd usually did not cause lumen compromise. These results
ere confirmed by three-vessel intravascular ultrasound
xamination, because multiple plaque ruptures were more
ommon in patients with acute myocardial infarction com-
ared with patients with SA (20). These results were also
onfirmed by angioscopy and recently by optical coherence
omography (4,21). Moreover, the widespread instability of
therosclerotic plaques extends also in carotid arteries,
ecause patients with unstable angina have morphologic
haracteristics of instability in carotid artery plaques (22).
ll of these studies challenge the concept of a single
ulnerable plaque in unstable coronary syndromes.
Other studies, however, support the idea that culprit
laques have distinct morphologic characteristics from non-
ulprit plaques and that the vascular event is determined by
able 5. Individual Data of the Study Population
No. Clinical Syndrome T (°C)
1 SA 0.02
2 ACS 0.10
3 ACS 0.05
4 SA 0.02
5 SA 0.02
6 SA 0.05
7 SA 0.04
8 SA 0.02
9 ACS 0.03
10 SA 0.06
11 ACS 0.10
12 SA 0.02
13 ACS 0.09
14 ACS 0.09
15 ACS 0.25
16 SA 0.01
17 SA 0.21
18 SA 0.01
19 ACS 0.05
20 SA 0.01
21 SA 0.20
22 ACS 0.08
23 ACS 0.14
24 SA 0.03
25 SA 0.03
26 ACS 0.16
27 ACS 0.10
28 ACS 0.05
29 SA 0.03
30 SA 0.05
31 ACS 0.07
32 ACS 0.14
33 ACS 0.29
34 ACS 0.02
35 SA 0.04
36 SA 0.02
37 ACS 0.02
38 ACS 0.20
39 SA 0.09
40 SA 0.07
41 SA 0.01
42 SA 0.04CS  acute coronary syndrome; SA  stable angina.
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January 17, 2006:301–6 Inflammation and Atherosclerosisre-event morphologies. Hoffmann et al. (10) have shown
hat local factors tend to be more important than patient
actors in determining the lesion morphology. Intravascular
ltrasound examination has shown that culprit plaques have
ore markers of instability (8–9).
Despite the large amount of information regarding the
orphologic characteristics of remote lesions, we lack stud-
es with functional assessment of non-culprit lesions. We
howed for the first time by coronary thermography, at least
o our knowledge, that non-culprit lesions have a tempera-
ure difference. It has been shown previously that culprit
esions produce heat, which can be detected in vivo by
everal catheter designs (16,23–26). This finding has been
ssociated with the local and systemic inflammatory status
n experimental and clinical studies (12,13,27–29). We
valuated local temperature differences in intermediate non-
ulprit lesions, and the results of the current study show that
eat is also generated in atheromatous plaques, which are
ot related by protocol to the clinical syndrome of the study
opulation. Moreover, in patients with ACS, a temperature
ncrease is observed in non-culprit lesions, supporting a
an-coronary inflammatory activation. We cannot draw safe
onclusions regarding the etiology of elevated temperature
n non-culprit lesions found in patients with ACS. It seems,
owever, that the increased temperature found in the
on-culprit lesions of patients with ACS is not a secondary
henomenon, because in patients with chronic SA (30%)
levated temperature was also found. Another observation
upporting this concept is the prolonged temperature ele-
ations in culprit lesions observed in patients investigated
fter the acute phase of myocardial infarction (15).
The findings of the present study suggest that statin
dministration seems to have a beneficial effect on non-
ulprit lesion temperature difference. Previous studies have
hown that statin administration is associated with reduced
eat generation from culprit lesions (17). The results of this
tudy support that the pleiotropic effects of statins are
igure 2. The difference in atherosclerotic plaque temperature from
roximal vessel wall temperature (T) in non-culprit lesions in untreated
atients and in patients under statin treatment. The bottom of the box
epresents the first quartile, the top of the box represents the third quartile,
nd the line in the box represents the median valuemplicated also in non-culprit atheromatic plaques. Thisoncept, however, needs to be confirmed in studies with a
arger number of patients.
tudy limitations. Although the study group was rather
mall, the conclusions of the study are supported by our
ndings. Non-culprit lesions were angiographically inter-
ediate, and therefore the conclusions cannot be extrapo-
ated to stenoses 50% or in significant lesions. However,
he treatment of lesions provoking significant stenosis is not
he major problem in the clinical practice, because interven-
ion is usually performed. Intermediate stenoses need to be
urther evaluated, morphologically and functionally, because
he decision for intervention is not always clear. Stenoses
50% are also important and should be evaluated for
revention of future ACS. However, the coronary thermog-
aphy catheter used in the current study cannot exclude the
ooling effect of blood flow (30–33), and therefore safe
onclusions cannot be drawn in low-grade stenoses. In the
resent study, a trend toward larger minimal lumen diam-
ter was observed in patients with SA compared with
atients with ACS. However, there was no correlation
etween minimal lumen diameter and T. Finally, regard-
ng the issue of collection of temperature recordings, the
perators had no knowledge of the temperature measure-
ents, because these were performed by technician opera-
ors, and the analysis of temperature differences was per-
ormed blindly.
Although the favorable effect of statins was shown in this
tudy, in the multivariate analysis statistical significance was
ot achieved. However, we must mention that the effect of
tatins in this study population was not the primary target of
he current study and a post hoc analysis was performed.
ONCLUSIONS
on-culprit intermediate lesions have temperature differ-
nce that is increased in patients with angiotensin-
onverting enzyme. The results of this study support the
oncept of global coronary instability. Moreover, statins
eem to have a favorable effect on heat generation from
on-culprit lesions.
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